📍 San Francisco, CA
Viz.ai logo
Private Company

Viz.ai

Medical AI company detecting time-sensitive conditions from medical imaging. Nearly 2,000 hospitals covering 230 million lives. Achieved profitability in healthcare business (2025). Multiple FDA clearances including ICH Plus (Dec 2025) and first-ever subdural measurements (June 2025). Pharma partnerships with Sanofi/Regeneron and Novartis. $1.2B valuation.

Listen to this lesson

Free preview · first 0:30
0:00 / 0:30

Audio & video lessons are paid features

Plus unlocks audio streaming. Pro adds downloadable audio, video, certificates, and more.

Plus adds:
  • Audio streaming
  • Downloadable PDFs
  • All AI Playbooks
  • Personalized content
Pro also adds:
  • Certificates of completion
  • Audio MP3 downloads
  • Video lessonssoon
  • & More…soon

Watch this lesson

Video coming soon

Learn About Viz.ai's AI Products

Create a free account to access in-depth lessons on each tool and model.

Start Learning Free

📋About Viz.ai

Updated June 15, 2026

Viz.ai is a healthcare AI company that develops AI-powered clinical decision support tools for detecting and triaging time-sensitive medical conditions. Founded in 2016 by Chris Mansi (a neurosurgeon) and David Golan, the company has FDA clearance for multiple AI algorithms and is used in over 1,800 hospitals.

Viz.ai's platform automatically analyzes medical images (CT scans, ECGs, ultrasounds) using AI algorithms to detect conditions like large vessel occlusion strokes, pulmonary embolisms, aortic dissections, and intracranial hemorrhages. When a critical finding is detected, the system instantly alerts the relevant specialist team — bypassing traditional communication chains that can delay life-saving treatment by hours. The platform has been shown to significantly reduce treatment times for stroke patients.

Viz.ai's clinical integration sets it apart from many healthcare AI companies — the system is embedded in hospital workflows, runs 24/7 on incoming scans, and takes autonomous action (alerting specialists) rather than waiting for human review. The company's expanding library of AI algorithms, growing hospital network, and demonstrated clinical impact make it one of the most commercially successful deployments of AI in acute healthcare.

🛠️Products & Tools (1)

Viz.aiEnterpriseHealthcare AI

Medical AI platform detecting time-sensitive conditions from imaging. Nearly 2,000 hospitals, 230 million lives covered. FDA-cleared tools for stroke, hemorrhage, pulmonary embolism, and more.